ANI PHARMACEUTICALS, INC Investing Cash Flow
ANI PHARMACEUTICALS, INC (ANIP) reported Investing Cash Flow of -$14.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$3.05M.
- ANI PHARMACEUTICALS, INC net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$11.32M.
- ANI PHARMACEUTICALS, INC net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$1.40M.
- ANI PHARMACEUTICALS, INC net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$6.16M.
- ANI PHARMACEUTICALS, INC net cash provided by (used in) investing activities for fiscal 2025 was -$34.32M.
- ANI PHARMACEUTICALS, INC net cash provided by (used in) investing activities for fiscal 2024 was -$404.72M.
- ANI PHARMACEUTICALS, INC net cash provided by (used in) investing activities for fiscal 2023 was -$18.51M.
- ANI PHARMACEUTICALS, INC net cash provided by (used in) investing activities for fiscal 2022 was -$15.74M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$14.38M 10-Q · filed 2026-08-07 | -$15.78M derived: sum of 3 quarters · filed 2026-08-07 | -$21.94M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | -$11.32M 10-Q · filed 2026-05-08 | -$12.73M derived: sum of 2 quarters · filed 2026-05-08 | -$18.89M derived: sum of 3 quarters · filed 2026-05-08 | -$25.80M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$7.57M derived: sum of 2 quarters · filed 2026-02-27 | -$14.47M derived: sum of 3 quarters · filed 2026-08-07 | -$34.32M 10-K · filed 2026-02-27 | |
| 2025-09-30 | -$6.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$13.07M derived: sum of 2 quarters · filed 2026-08-07 | -$32.92M 10-Q · filed 2025-11-07 | -$43.60M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | -$6.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$26.75M 10-Q · filed 2026-08-07 | -$37.44M derived: sum of 3 quarters · filed 2026-08-07 | -$435.96M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | -$19.85M 10-Q · filed 2026-05-08 | -$30.53M derived: sum of 2 quarters · filed 2026-05-08 | -$429.05M derived: sum of 3 quarters · filed 2026-05-08 | -$433.50M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$10.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$409.20M derived: sum of 2 quarters · filed 2026-02-27 | -$413.65M derived: sum of 3 quarters · filed 2026-02-27 | -$404.72M 10-K · filed 2026-02-27 | |
| 2024-09-30 | -$398.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$402.97M derived: sum of 2 quarters · filed 2025-11-07 | -$394.04M 10-Q · filed 2025-11-07 | -$398.82M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | -$4.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $4.48M 10-Q · filed 2025-08-08 | -$295.00K derived: sum of 3 quarters · filed 2026-02-27 | -$4.85M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $8.93M 10-Q · filed 2025-05-09 | $4.15M derived: sum of 2 quarters · filed 2026-02-27 | -$399.00K derived: sum of 3 quarters · filed 2026-02-27 | -$7.22M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | -$4.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$9.33M derived: sum of 2 quarters · filed 2026-02-27 | -$16.16M derived: sum of 3 quarters · filed 2026-02-27 | -$18.51M 10-K · filed 2026-02-27 | |
| 2023-09-30 | -$4.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$11.38M derived: sum of 2 quarters · filed 2024-11-08 | -$13.73M 10-Q · filed 2024-11-08 | -$16.87M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | -$6.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$9.18M 10-Q · filed 2024-08-06 | -$12.32M derived: sum of 3 quarters · filed 2025-02-28 | -$22.14M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | -$2.35M 10-Q · filed 2024-05-10 | -$5.50M derived: sum of 2 quarters · filed 2025-02-28 | -$15.31M derived: sum of 3 quarters · filed 2025-02-28 | -$15.91M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$12.96M derived: sum of 2 quarters · filed 2025-02-28 | -$13.56M derived: sum of 3 quarters · filed 2025-02-28 | -$15.74M 10-K · filed 2025-02-28 | |
| 2022-09-30 | -$9.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$10.42M derived: sum of 2 quarters · filed 2023-11-08 | -$12.60M 10-Q · filed 2023-11-08 | -$94.81M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | -$604.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$2.78M 10-Q · filed 2023-08-09 | -$85.00M derived: sum of 3 quarters · filed 2024-02-29 | -$85.58M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | -$2.18M 10-Q · filed 2023-05-08 | -$84.39M derived: sum of 2 quarters · filed 2024-02-29 | -$84.97M derived: sum of 3 quarters · filed 2024-02-29 | -$106.92M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | -$82.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$82.80M derived: sum of 2 quarters · filed 2024-02-29 | -$104.75M derived: sum of 3 quarters · filed 2024-02-29 | -$105.48M 10-K · filed 2024-02-29 | |
| 2021-09-30 | -$583.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$22.53M derived: sum of 2 quarters · filed 2022-11-09 | -$23.27M 10-Q · filed 2022-11-09 | -$25.39M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-06-30 | -$21.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$22.69M 10-Q · filed 2022-08-08 | -$24.81M derived: sum of 3 quarters · filed 2023-03-09 | -$30.61M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-03-31 | -$737.00K 10-Q · filed 2022-05-10 | -$2.86M derived: sum of 2 quarters · filed 2023-03-09 | -$8.66M derived: sum of 3 quarters · filed 2023-03-09 | -$11.51M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2020-12-31 | -$2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$7.93M derived: sum of 2 quarters · filed 2023-03-09 | -$10.78M derived: sum of 3 quarters · filed 2023-03-09 | -$68.32M 10-K · filed 2023-03-09 | |
| 2020-09-30 | -$5.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | -$8.66M derived: sum of 2 quarters · filed 2021-11-01 | -$66.20M 10-Q · filed 2021-11-01 | -$67.58M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-06-30 | -$2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$60.39M 10-Q · filed 2021-08-06 | -$61.77M derived: sum of 3 quarters · filed 2022-03-15 | -$63.70M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-03-31 | -$57.55M 10-Q · filed 2021-05-07 | -$58.92M derived: sum of 2 quarters · filed 2022-03-15 | -$60.85M derived: sum of 3 quarters · filed 2022-03-15 | -$64.81M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2019-12-31 | -$1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$3.31M derived: sum of 2 quarters · filed 2022-03-15 | -$7.26M derived: sum of 3 quarters · filed 2022-03-15 | -$27.55M 10-K · filed 2022-03-15 | |
| 2019-09-30 | -$1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$5.89M derived: sum of 2 quarters · filed 2020-11-05 | -$26.18M 10-Q · filed 2020-11-05 | -$26.58M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-06-30 | -$3.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$24.24M 10-Q · filed 2020-08-06 | -$24.65M derived: sum of 3 quarters · filed 2021-03-11 | -$43.09M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-03-31 | -$20.29M 10-Q · filed 2020-05-07 | -$20.69M derived: sum of 2 quarters · filed 2021-03-11 | -$39.13M derived: sum of 3 quarters · filed 2021-03-11 | -$45.39M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2018-12-31 | -$407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$18.85M derived: sum of 2 quarters · filed 2021-03-11 | -$25.10M derived: sum of 3 quarters · filed 2021-03-11 | -$27.38M 10-K · filed 2021-03-11 | |
| 2018-09-30 | -$18.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$24.69M derived: sum of 2 quarters · filed 2019-11-06 | -$26.97M 10-Q · filed 2019-11-06 | -$77.09M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | -$6.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$8.53M 10-Q · filed 2019-08-07 | -$58.65M derived: sum of 3 quarters · filed 2020-02-27 | -$61.13M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | -$2.28M 10-Q · filed 2019-05-09 | -$52.39M derived: sum of 2 quarters · filed 2020-02-27 | -$54.87M derived: sum of 3 quarters · filed 2020-02-27 | -$57.18M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | -$50.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$52.59M derived: sum of 2 quarters · filed 2020-02-27 | -$54.90M derived: sum of 3 quarters · filed 2020-02-27 | -$107.99M 10-K · filed 2020-02-27 | |
| 2017-09-30 | -$2.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$4.78M derived: sum of 2 quarters · filed 2018-11-06 | -$57.88M 10-Q · filed 2018-11-06 | -$59.27M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | -$2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$55.40M 10-Q · filed 2018-08-07 | -$56.79M derived: sum of 3 quarters · filed 2019-02-27 | -$57.88M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | -$53.09M 10-Q · filed 2018-05-08 | -$54.48M derived: sum of 2 quarters · filed 2019-02-27 | -$55.57M derived: sum of 3 quarters · filed 2019-02-27 | -$116.60M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$2.48M derived: sum of 2 quarters · filed 2019-02-27 | -$63.51M derived: sum of 3 quarters · filed 2019-02-27 | -$149.06M 10-K · filed 2019-02-27 | -$154.06M 10-K · filed 2017-03-02 |
| 2016-09-30 | -$1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$62.12M derived: sum of 2 quarters · filed 2017-11-02 | -$147.67M 10-Q · filed 2017-11-02 | -$148.78M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | -$61.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$146.58M 10-Q · filed 2017-08-03 | -$147.69M derived: sum of 3 quarters · filed 2018-02-27 | -$174.46M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-03-31 | -$85.55M 10-Q · filed 2017-05-04 | -$86.66M derived: sum of 2 quarters · filed 2018-02-27 | -$113.42M derived: sum of 3 quarters · filed 2018-02-27 | -$113.62M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2015-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$27.87M derived: sum of 2 quarters · filed 2018-02-27 | -$28.07M derived: sum of 3 quarters · filed 2018-02-27 | -$32.68M 10-K · filed 2018-02-27 | |
| 2015-09-30 | -$26.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | -$26.97M derived: sum of 2 quarters · filed 2015-11-03 | -$31.58M 10-Q · filed 2015-11-03 | -$31.92M derived: sum of 4 quarters · filed 2017-03-02 | |
| 2015-06-30 | -$198.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$4.81M 10-Q · filed 2015-08-04 | -$5.15M derived: sum of 3 quarters · filed 2017-03-02 | -$27.68M derived: sum of 4 quarters · filed 2017-03-02 | |
| 2015-03-31 | -$4.61M 10-Q · filed 2015-05-05 | -$4.95M derived: sum of 2 quarters · filed 2017-03-02 | -$27.48M derived: sum of 3 quarters · filed 2017-03-02 | -$27.73M derived: sum of 4 quarters · filed 2017-03-02 | |
| 2014-12-31 | -$338.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | -$22.87M derived: sum of 2 quarters · filed 2017-03-02 | -$23.12M derived: sum of 3 quarters · filed 2017-03-02 | -$35.75M 10-K · filed 2017-03-02 | |
| 2014-09-30 | -$22.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | -$22.78M derived: sum of 2 quarters · filed 2015-11-03 | -$35.42M 10-Q · filed 2015-11-03 | ||
| 2014-06-30 | -$253.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$12.89M 10-Q · filed 2015-08-04 | |||
| 2014-03-31 | -$12.63M 10-Q · filed 2015-05-05 | ||||
| 2011-09-30 | -$102.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$645.60K 10-Q · filed 2011-11-09 | |||
| 2011-06-30 | -$542.92K 10-Q · filed 2011-08-05 | ||||
| 2010-09-30 | -$2.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$26.68K 10-Q · filed 2011-11-09 | |||
| 2010-06-30 | -$23.79K 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |